Recent News

• 09.03.2025 - SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes
• 08.07.2025 - SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates
• 07.21.2025 - SAB BIO Announces Oversubscribed $175 Million Private Placement
• 07.09.2025 - SAB BIO 2025 R&D PRESENTATION

Recent Filings

• 09.02.2025 - S-3 Registration statement under Securities Act of 1933
• 08.29.2025 - DEF 14A Other definitive proxy statements
• 08.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.19.2025 - PRE 14A Other preliminary proxy statements
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.05.2025 - D Notice of Exempt Offering of Securities